Release Date: 30/04/12 17:53 Summary: Quarterly Activities Report and Appendix 5B Price Sensitive: Yes Download Document 939.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%